Cabozantinib for advanced hepatocellular carcinoma

被引：2
|
作者：
Kudo, Masatoshi [1 ]
机构：
[1] Kindai Univ, Fac Med, Osaka, Japan
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2019年 / 8卷 / 02期
关键词：
SYSTEMIC THERAPY; DOUBLE-BLIND; REGORAFENIB; SORAFENIB; MULTICENTER; ANGIOGENESIS; PLACEBO; MET;
D O I：
10.21037/hbsn.2018.11.22
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：153 / 156
页数：4
相关论文
共 50 条
  • [41] Cabozantinib in Advanced Renal Cell Carcinoma: Is it a METEOR?
    Ciccarese, Chiara
    Massari, Francesco
    Tortora, Giampaolo
    [J]. EUROPEAN UROLOGY, 2016, 69 (05) : 969 - 970
  • [42] EGFR blockade confers sensitivity to cabozantinib in hepatocellular carcinoma
    Xuhui Ma
    Shanshan Wu
    Botai Li
    Qianqian Zhang
    Jianming Zhang
    Wenming Liu
    Hexin Yan
    René Bernards
    Wenxin Qin
    Cun Wang
    [J]. Cell Discovery, 8
  • [43] Cabozantinib: A Review in Advanced Renal Cell Carcinoma
    Al-Salama, Zaina T.
    Keating, Gillian M.
    [J]. DRUGS, 2016, 76 (18) : 1771 - 1778
  • [44] EGFR blockade confers sensitivity to cabozantinib in hepatocellular carcinoma
    Ma, Xuhui
    Wu, Shanshan
    Li, Botai
    Zhang, Qianqian
    Zhang, Jianming
    Liu, Wenming
    Yan, Hexin
    Bernards, Rene
    Qin, Wenxin
    Wang, Cun
    [J]. CELL DISCOVERY, 2022, 8 (01)
  • [45] Multisite institutional study of efficacy and safety of cabozantinib following immunotherapy in patients with advanced hepatocellular carcinoma.
    Palmer, Mathias Earl
    Storandt, Michael H.
    Gile, Jennifer
    Zemla, Tyler J.
    Bekaii-Saab, Tanios S.
    Jin, Zhaohui
    Tran, Nguyen H.
    Mahipal, Amit
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 559 - 559
  • [46] Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
    Won Jin Ho
    Qingfeng Zhu
    Jennifer Durham
    Aleksandra Popovic
    Stephanie Xavier
    James Leatherman
    Aditya Mohan
    Guanglan Mo
    Shu Zhang
    Nicole Gross
    Soren Charmsaz
    Dongxia Lin
    Derek Quong
    Brad Wilt
    Ihab R. Kamel
    Matthew Weiss
    Benjamin Philosophe
    Richard Burkhart
    William R. Burns
    Chris Shubert
    Aslam Ejaz
    Jin He
    Atul Deshpande
    Ludmila Danilova
    Genevieve Stein-O’Brien
    Elizabeth A. Sugar
    Daniel A. Laheru
    Robert A. Anders
    Elana J. Fertig
    Elizabeth M. Jaffee
    Mark Yarchoan
    [J]. Nature Cancer, 2021, 2 : 891 - 903
  • [47] The use of cabozantinib in advanced hepatocellular carcinoma (HCC): Hong Kong multi-center experience.
    Dong Yawen
    Leung, Thomas Wai-Tong
    Kwok, Gin Wai
    Tang, Vikki
    Li, Bryan
    Leung, Roland Ching-Yu
    Chiu, Joanne Wing Yan
    Wong, Jeffrey Sum Lung
    Ma, Ka Wing
    She, Wong Hoi
    Tsang, Wing Yan Josephine
    Cheung, Tan To
    Yau, Thomas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [48] Feasibility and efficacy of neoadjuvant cabozantinib and nivolumab in patients with borderline resectable or locally advanced hepatocellular carcinoma (HCC).
    Yarchoan, Mark
    Zhu, Qingfeng
    Durham, Jennifer N.
    Gross, Nicole
    Charmsaz, Soren
    Leatherman, James M.
    Zhang, Shu
    Popovic, Aleksandra
    Weiss, Matthew John
    Philosophe, Benjamin
    Burkhart, Richard A.
    Burns, William
    Wilt, Brad
    Sugar, Elizabeth
    Fertig, Elana J.
    Laheru, Dan
    Anders, Robert A.
    Jaffee, Elizabeth M.
    Ho, Won Jin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [49] The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong-A Territory-Wide Cohort Study
    Wong, Jeffrey Sum-Lung
    Dong, Yawen
    Tang, Vikki
    Leung, Thomas
    Yeung, Cynthia S. Y.
    Tai, Anna
    Law, Ada
    Shum, Tracy
    Kwok, Gerry Gin-Wai
    Li, Bryan Cho-Wing
    Leung, Roland
    Chiu, Joanne
    Ma, Ka-Wing
    She, Wong-Hoi
    Tsang, Josephine
    Cheung, Tan-To
    Yau, Thomas
    [J]. CANCERS, 2021, 13 (09)
  • [50] Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
    Ho, Won Jin
    Zhu, Qingfeng
    Durham, Jennifer
    Popovic, Aleksandra
    Xavier, Stephanie
    Leatherman, James
    Mohan, Aditya
    Mo, Guanglan
    Zhang, Shu
    Gross, Nicole
    Charmsaz, Soren
    Lin, Dongxia
    Quong, Derek
    Wilt, Brad
    Kamel, Ihab R.
    Weiss, Matthew
    Philosophe, Benjamin
    Burkhart, Richard
    Burns, William R.
    Shubert, Chris
    Ejaz, Aslam
    He, Jin
    Deshpande, Atul
    Danilova, Ludmila
    Stein-O'Brien, Genevieve
    Sugar, Elizabeth A.
    Laheru, Daniel A.
    Anders, Robert A.
    Fertig, Elana J.
    Jaffee, Elizabeth M.
    Yarchoan, Mark
    [J]. NATURE CANCER, 2021, 2 (09) : 891 - +
12345